UCB Ventures and GV returned for the neurodegenerative, neuromuscular and retinal disease drug developer’s series B round.
Month: December 2020
UK leads in quantum academia-industry ties
The UK moves to second phase of quantum initiative, programme links universities to industries at tech hubs, ‘Ion traps’ alternative to superconductors are a key focus
AI face-off: China battles the US while EU plays catch up
China is benefiting from its government’s focus on artificial intelligence (AI) with unlisted companies having raised RMB203.7m ($30bn) in venture capital since 2016, according to Nikkei Asia Tech and 36kr.
Ethics in artificial intelligence
GCV’s AI Q4 2020 supplement editorial by James Mawson, editor in chief, Global Corporate Venturing
Hibob lets rip with $70m series B
Seek will take a board seat at HR and employee management platform developer Hibob having co-led a round that pushed its total funding to $124m.
Befor Capital taps corporates for latest funds
Canadian Solar has helped the venture capital firm push its total fundraising past the $300m mark with the first close of its two newest funds.
Rani reaps $69m in series E funding
Drug release technology developer Rani has now raised $211m in all, from investors including GV, Novartis, Ping An Ventures, KPC, AstraZeneca and Stevanato.
Car-sharing seeds future opportunities
There has been a steep decline in corporate interest in car sharing-type deals this past year according to GCV Analytics. This is perhaps of little surprise given the covid-19 pandemic has closed off or made many people uncomfortable in shared spaces. But some interesting deals have come out of the ashes of the 10-fold drop… Continue reading Car-sharing seeds future opportunities
Iris avoids obstacles to raise $13m
Sony Innovation Fund and Verizon Ventures came onboard as the drone avoidance system developer closed its series B round.
Eta Compute eats up series C funding
The energy-processing technology provider has raised $12.5m in a round led by newly minted strategic partner Synaptics.
CG Oncology sees its way to $47m
Kissei Pharmaceutical has become the cancer immunotherapy developer’s first corporate investor, in a series D round bringing its overall funding to $93.5m.
Nekuino hits next stage with new funding
Jafco has led a round of undisclosed size for the All About, Nippon Life, KLab and Credit Saison-backed teleconsultation technology developer, taking its total funding to nearly $20m.
Temasek segues into Info Edge fund
Temasek has pumped $51.5m into classified listings operator Info Edge’s debut consumer technology fund, bringing its corpus to almost two thirds of its $100m ceiling.
Fabric Tokyo threads in $13m
Marui’s D2C&Co unit, Pola Orbis and Takram were among the investors that helped the online bespoke suit vendor reach the first close of a convertible bond and debt financing round.